07_coagulation clinical issues
DESCRIPTION
TMH proceedings 2010-2011,pdfTRANSCRIPT
![Page 1: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/1.jpg)
1
Coagulation : Case based approach 2nd Basic hematopathology course, TMH, MumbaiSaturday, 11th June 2011
Dr. M.B. Agarwal, MD, MNAMSHead, Dept of Haematology, Bombay Hospital Inst of Med Sc, Mumbai
![Page 2: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/2.jpg)
2Bleeding disorders
![Page 3: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/3.jpg)
3
Case 1
![Page 4: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/4.jpg)
4
• Jigar, 15-year old boy from Vadodara with
post-traumatic nasal & oral bleeding : 2 hours
• No family h/o bleeding disorder
![Page 5: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/5.jpg)
5
Jigar : Lab. investigations
Tests Results Control
Hb 13.3 g/dl
Haematocrit 41.4 %
WBC 7900/cmm
Platelets 368,000/cmm
PT 11 s 11 s
PTT 46 s 28 s
![Page 6: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/6.jpg)
6
Differential diagnosis
![Page 7: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/7.jpg)
7
Factor deficiencyor
Inhibitors
![Page 8: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/8.jpg)
8
Test Result Control
PTT 46 s 28 s
PTT mix (1:1) 30 s
What does this mean ?
![Page 9: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/9.jpg)
9
Factor deficiency
![Page 10: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/10.jpg)
10
Test Result Control
PTT 46 s 28 s
PTT mix (1:1) 43 s
What does this mean ?(46 + 28 = 74 ÷ 2 = 37)
![Page 11: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/11.jpg)
11
Inhibitors
Factor specific Lupus type
![Page 12: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/12.jpg)
12
Inhibitors
Factor specific Lupus type• KCT• dRVVT• L1 / L2 > 1.3
• Factor assay
![Page 13: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/13.jpg)
13
Normal coagulation cascade
![Page 14: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/14.jpg)
14
Intrinsic pathway defect
• Factor VIII deficiency including von Willebrand Disease
• Factor IX deficiency
• Factor XI deficiency (rare)
• Factor XII deficiency (non-bleeder)
![Page 15: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/15.jpg)
15
Test Result Normal
Factor VIII : C 9 % 50 - 150 %
Factor IX 77 % 50 - 150 %
What does this mean ?
![Page 16: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/16.jpg)
16
Classical haemophilia Aor
von Willebrand Disease
![Page 17: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/17.jpg)
17
vWD has equal prevalence in both sexes (Autosomal)
![Page 18: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/18.jpg)
18
Coming back to Jigar
• Bleeding from nose • Raised PTT• Good correction on mixing studies• Low factor VIII : C
![Page 19: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/19.jpg)
19
Jigar : Further work up
Test Result Normal
VIII : C 9% 50-150%
vWF : Ag 12 % 60-150 %
vWF : RCoF 10 % 50-150 %
![Page 20: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/20.jpg)
20
Jigar : Final diagnosis
![Page 21: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/21.jpg)
21
Von Willebrand Disease
![Page 22: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/22.jpg)
22
vWD : Primary classification
Subtypes vWF
Type 1 Partial deficiency (AD)
Type 2 Qualitative defect (AD)
Type 3 Total deficiency (AR)
![Page 23: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/23.jpg)
23
vWD type 2 : sub classificationSubtypes Characteristics DD
2A* High mol wt vWF multimers absent
vWD : Type 1 & Type 2M
2B*Low and High mol wt vWF ↓
↑ RIPAThrombocytopenia
2M*High mol wt vWF multimers normal
↓ vWF : CBvWD : Type 2A
2N** Markedly ↓ affinity for factor VIII Haemophilia
*vWF : Ag > vWF : Rco, **AR
![Page 24: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/24.jpg)
24
vWD : Laboratory tests• CBC, platelet count, PT : Normal• PTT : often normal• Factor VIII (coagulometer)• vWF : RCoF (aggregometry)• vWF : CB (ELISA)• vWF : Ag (ELISA)• RIPA : Aggregometry• vWF : Multimer analysis (gel electrophoresis)
![Page 25: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/25.jpg)
25
Variations in vWF levels ()
• Exercise and stress (adrenaline)
• Infection and inflammation
• Liver disease
• Pregnancy
• Estrogen and progesterone therapy
• Hyperthyroidism
![Page 26: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/26.jpg)
26
Genetic variations in vWF levels
• Blood group O has lowest level• Black race has higher level• Black with non A may have double the level of
a Caucasian with group O• Degree of proteolysis varies• ADAMTS-13 activity varies
![Page 27: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/27.jpg)
27
Platelet-type vWD• It is not vWD• A genetic platelet disorder (AD)• A gain-of-function mutation• affinity of platelet GP1b for vWF• RIPA• Thrombocytopenia• Phenotype : similar to type 2B• Treatment : platelet transfusion and not vWF
![Page 28: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/28.jpg)
28
Acquired vWD
• Not an uncommon disease
• Pts with autoimmune disorders, hypothyroidism, lymphoma, WM
• Antibodies are present only in a minority
• Excessive proteolysis or consumption (AS)
![Page 29: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/29.jpg)
29
Associations
• Angiodysplastic lesions in gut
• Atherosclerosis (pigs)
• Diagnosis may be totally missed during pregnancy and early puerperium
• Factor VIII level may vary within the family
• Role of PFA-100
![Page 30: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/30.jpg)
30
![Page 31: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/31.jpg)
31
Case 2
![Page 32: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/32.jpg)
32
Case study
• Mr. Raj, 69y from Rajkot • SC hematomas & easy bruising : 2 mths• Platelet count : 3,32,000/cmm• PT : 43/12 secs, INR 3.7• PTT : 56/30 secs
![Page 33: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/33.jpg)
33
What is the differential diagnosis ?
![Page 34: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/34.jpg)
34
Whenever PT & PTT both are raised ……?
![Page 35: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/35.jpg)
35
First,
we must exclude
difficult collection
(partially clotted blood)
![Page 36: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/36.jpg)
36
We must also excludeeffect of high haematocrit
(polycythemia)
![Page 37: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/37.jpg)
37
• Common pathway defect
• Vitamin K deficiency
• Chronic liver disease
• Consumptive coagulopathy
• Anticoagulant therapy
![Page 38: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/38.jpg)
38
• Liver function : normal
• DIC profile : normal
![Page 39: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/39.jpg)
39
Raj : Mixing studies
Test PT PTT
Raj 43 56Control 12 30
4 : 1 mix 15 35
![Page 40: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/40.jpg)
40
Factor I : 290 mg/dl
Factor II : 87%
Factor V : 78%
Factor X : 1.2%
![Page 41: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/41.jpg)
41
What is the aetiology of
selective factor X deficiency at the age of
69 years ?
![Page 42: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/42.jpg)
42
![Page 43: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/43.jpg)
43
Amyloidosis
![Page 44: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/44.jpg)
44
Raj : Amyloidosis• Macroglossia
• S. Protein electrophoresis : Faint M band present
• S. Immunofixation : Lambda monoclonal gammopathy
• Bone marrow : Plasma cells : 2-3%
• Bone marrow biopsy : Amyloidosis
• Abdominal fat pad biopsy : Amyloidosis
![Page 45: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/45.jpg)
45
Part 3
Pictorial quiz
![Page 46: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/46.jpg)
46
![Page 47: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/47.jpg)
47
![Page 48: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/48.jpg)
48
![Page 49: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/49.jpg)
49
What is this ?
![Page 50: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/50.jpg)
50
![Page 51: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/51.jpg)
51
![Page 52: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/52.jpg)
52
![Page 53: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/53.jpg)
53
Blue toe syndrome
![Page 54: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/54.jpg)
54
CoaguloChek
![Page 55: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/55.jpg)
55
![Page 56: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/56.jpg)
56
Conclusion
![Page 57: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/57.jpg)
57
XVIIIth National CME in Haematology & Haemato-oncology on
26th - 29th of January 2012 (Thurs - Sun)at
Bombay Hospital Inst of Med Sc, Mumbai
( Subsidised registration to participants submitting registration form today)
![Page 58: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/58.jpg)
58Thank You
![Page 59: 07_Coagulation Clinical Issues](https://reader034.vdocuments.us/reader034/viewer/2022042604/577cc7841a28aba711a12fb1/html5/thumbnails/59.jpg)
59
Questions
?